1. Pharmacokinetics of Cefquinome in Camels
2. COMMITTEE FORVETERINARYMEDICALPRODUCTS(1995) Cefquinome. Summary report. EMEA/MRL/005/95. European Agency for the Evaluation of Medicinal Products, London, UK. Available: http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500011877.pdf. Accessed 25 April 2010
3. COMMITTEE FORVETERINARYMEDICALPRODUCTS(1999) Cefquinome (Extension to Pigs). Summary Report (2). EMEA/MRL/545/99-FINAL. European Agency for the Evaluation of Medicinal Products, London, UK. Available: http://www.emea.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500011890.pdf. Accessed 25 April 2010
4. COMMITTEE FORVETERINARYMEDICALPRODUCTS(2003) Cefquinome (Extension to horses) Summary Report (3). MEA/MRL/883/03-FINAL. European Agency for the Evaluation of Medicinal Products, London, UK. Available: http://www.emea.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500011892.pdf. Accessed 25 April 2010
5. State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men